| Andrew Bussman, OT | |
|
524 W Iola St, Broken Arrow, OK 74012-2564 | |
| (918) 994-5333 | |
| (918) 994-5334 |
| Full Name | Andrew Bussman |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapy |
| Experience | 12 Years |
| Location | 524 W Iola St, Broken Arrow, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831456771 | NPI | - | NPPES |
| 200569700A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XH1200X | Occupational Therapist - Hand | (* (Not Available)) | Secondary |
| 225XH1200X | Occupational Therapist - Hand | 1777 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Orthopedics Of Oklahoma Pllc | 8426320912 | 69 |
News Archive
Anyone who has suffered through sleepless nights due to uncontrollable itching knows that not all itching is the same. New research at Washington University School of Medicine in St. Louis explains why.
Australian researchers have found a way to boost the effectiveness and cross-protective capabilities of an influenza A vaccine by adding a simple component. Published this week in mBio, an online open-access journal of the American Society for Microbiology, the research in mice could lead to better seasonal flu vaccines for humans, and also vaccines that could provide community protection in the early stages of an outbreak of a novel flu virus strain.
Scientists have identified weak spots in cancer cells that could be targeted and attacked by new precision drugs.
Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.
For decades, scientists have thought the faulty neural wiring that predisposes individuals to behavioral disorders like autism and psychiatric diseases like schizophrenia must occur during development. Even so, no one has ever shown that a risk gene for the disease actually disrupts brain development.
› Verified 9 days ago
| Provider Name | Advanced Orthopedics Of Oklahoma Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235676453 PECOS PAC ID: 8426320912 Enrollment ID: O20170817003088 |
News Archive
Anyone who has suffered through sleepless nights due to uncontrollable itching knows that not all itching is the same. New research at Washington University School of Medicine in St. Louis explains why.
Australian researchers have found a way to boost the effectiveness and cross-protective capabilities of an influenza A vaccine by adding a simple component. Published this week in mBio, an online open-access journal of the American Society for Microbiology, the research in mice could lead to better seasonal flu vaccines for humans, and also vaccines that could provide community protection in the early stages of an outbreak of a novel flu virus strain.
Scientists have identified weak spots in cancer cells that could be targeted and attacked by new precision drugs.
Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.
For decades, scientists have thought the faulty neural wiring that predisposes individuals to behavioral disorders like autism and psychiatric diseases like schizophrenia must occur during development. Even so, no one has ever shown that a risk gene for the disease actually disrupts brain development.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Bussman, OT 2488 E 81st St Ste 290, Tulsa, OK 74137-4265 Ph: (918) 927-3737 | Andrew Bussman, OT 524 W Iola St, Broken Arrow, OK 74012-2564 Ph: (918) 994-5333 |
News Archive
Anyone who has suffered through sleepless nights due to uncontrollable itching knows that not all itching is the same. New research at Washington University School of Medicine in St. Louis explains why.
Australian researchers have found a way to boost the effectiveness and cross-protective capabilities of an influenza A vaccine by adding a simple component. Published this week in mBio, an online open-access journal of the American Society for Microbiology, the research in mice could lead to better seasonal flu vaccines for humans, and also vaccines that could provide community protection in the early stages of an outbreak of a novel flu virus strain.
Scientists have identified weak spots in cancer cells that could be targeted and attacked by new precision drugs.
Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.
For decades, scientists have thought the faulty neural wiring that predisposes individuals to behavioral disorders like autism and psychiatric diseases like schizophrenia must occur during development. Even so, no one has ever shown that a risk gene for the disease actually disrupts brain development.
› Verified 9 days ago
Mr. Minh The Huynh, OTL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3000 S Elm Pl, Broken Arrow, OK 74012 Phone: 918-451-5143 | |
Ms. Maryanne E. Damico, O.T.R. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2608 W Kenosha St, Suite 430, Broken Arrow, OK 74012 Phone: 918-259-3714 | |
Mrs. Carla Cathleen Lott, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2221 W Detroit St, Broken Arrow, OK 74012 Phone: 918-615-6492 | |
April Meyer, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1306 E College St, Broken Arrow, OK 74012 Phone: 918-251-3200 | |
Outcomes, Inc. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5900 S 283rd East Ave, Broken Arrow, OK 74014 Phone: 918-408-6943 Fax: 918-357-9277 | |
Ashlee Potter, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2257 W Washington St, Broken Arrow, OK 74012 Phone: 918-994-7799 | |
Alexis Langston, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4800 W San Antonio St, Broken Arrow, OK 74012 Phone: 918-410-8740 |